The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity
Higher doses of retatrutide were associated with reduced UACR in participants with T2D and obesity, and with increased eGFR in participants with obesity but not in those with T2D.
Authors
- Hiddo J.L. Heerspink (ORCID: https://orcid.org/0000-0002-3126-3730)
- Axel Haupt (ORCID: https://orcid.org/0000-0003-4502-0470)
- Tamer Coşkun (ORCID: https://orcid.org/0000-0002-2481-133X)
- Mark L. Hartman (ORCID: https://orcid.org/0000-0003-2396-7356)
- Kevin L. Duffin (ORCID: https://orcid.org/0000-0002-1656-8982)
- Yu Du (ORCID: https://orcid.org/0000-0002-1847-0743)
- Zeqing Lu (ORCID: https://orcid.org/0000-0002-0720-4693)
Institutions
- University Medical Center Groningen (NL)
- Eli Lilly (United States) (US)
- University of Groningen (NL)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1016/j.ekir.2025.03.049
- Citations
- 8
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 10.36
Funders
- Eli Lilly and Company